Shima Hadidchi, MD , offers a personalized approach to weight loss with Zepbound as part of a medically supervised plan designed to enhance long-term wellness and sustainable results
The company is on track to spend nearly $200 million by 2025, he added
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial
If you experience unusual muscle soreness beyond normal post-workout discomfort, discuss with your physician to rule out medication-related myalgia versus normal exercise-induced muscle damage
Stomach-related problems such as nausea, vomiting, pain, or bloating Among those newly starting semaglutide, gastrointestinal issues are the most frequently reported
Men in trials generally reported gastrointestinal side effects slightly less frequently than women